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Abstract
During embryonic development, a number of genetic cues act to generate neuronal diver-
sity. While intrinsic transcriptional cascades are well-known to control neuronal sub-type cell
fate, the target cells can also provide critical input to specific neuronal cell fates. Such sig-
nals, denoted retrograde signals, are known to provide critical survival cues for neurons, but
have also been found to trigger terminal differentiation of neurons. One salient example of
such target-derived instructive signals pertains to the specification of the Drosophila
FMRFamide neuropeptide neurons, the Tv4 neurons of the ventral nerve cord. Tv4 neurons
receive a BMP signal from their target cells, which acts as the final trigger to activate the
FMRFa gene. A recent FMRFa-eGFP genetic screen identified several genes involved in
Tv4 specification, two of which encode components of the U5 subunit of the spliceosome:
brr2 (l(3)72Ab) and Prp8. In this study, we focus on the role of RNA processing during tar-
get-derived signaling. We found that brr2 and Prp8 play crucial roles in controlling the
expression of the FMRFa neuropeptide specifically in six neurons of the VNC (Tv4 neurons).
Detailed analysis of brr2 revealed that this control is executed by two independent mecha-
nisms, both of which are required for the activation of the BMP retrograde signaling pathway
in Tv4 neurons: (1) Proper axonal pathfinding to the target tissue in order to receive the
BMP ligand. (2) Proper RNA splicing of two genes in the BMP pathway: the thickveins (tkv)
gene, encoding a BMP receptor subunit, and the Medea gene, encoding a co-Smad. These
results reveal involvement of specific RNA processing in diversifying neuronal identity within
the central nervous system.
Author summary
The nervous system displays daunting cellular diversity, largely generated through com-
plex regulatory input operating on stem cells and their neural lineages during develop-
ment. Most of the reported mechanisms acting to generate neural diversity pertain to
transcriptional regulation. In contrast, little is known regarding the post-transcriptional
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mechanisms involved. Here, we use a specific group of neurons, Apterous neurons, in the
ventral nerve cord of Drosophila melanogaster as our model, to analyze the function of
two essential components of the spliceosome; Brr2 and Prp8. Apterous neurons require a
BMP retrograde signal for terminal differentiation, and we find that brr2 and Prp8 play
crucial roles during this process. brr2 is critical for two independent events; axon path-
finding and BMP signaling, both of which are required for the activation of the retrograde
signaling pathway necessary for Apterous neurons. These results identify a post-transcrip-
tional mechanism as key for specifying neuronal identity, by ensuring the execution of a
retrograde signal.
Introduction
While transcriptional networks and signalling pathways have been a primary focus during the
neural specification processes, relatively little is known about how post-transcriptional modu-
lations control the identity of individual cells. Splicing mechanisms have been widely studied
and are known to play an essential role, not only during general mRNA processing, but also
as a a regulatory mechanism for generating cellular diversity during development [1–4]. Alter-
native splicing plays a major part in the generation of protein variation, through mRNA iso-
form generation, and can also act as a regulatory element, by establishing splicing patterns of
batteries of genes specific to certain cell types, tissues or even organisms[5]. Salient examples
of alternate splicing patterns stem from Drosophila, where sex determination is regulated by
dimorphic splicing of pre-mRNAs for Sex lethal, transformer, doublesex and fruitless [6]. In
addition, splicing factors can specify identity in a tissue, such as the splicing factor embryonic
lethal abnormal vision (elav), which promotes the production of the Ngr180 neuroglia-specific
isoform in the nervous system, as opposed to the ubiquitous Ngr167 isoform [7]. However, to
what extent splicing determines specific cell identities is not well understood.
The Drosophila Ap cluster is an excellent model for studying mechanisms involved in neu-
ral specification in the central nervous system (CNS). The Ap cluster is a well-studied subset of
four neurons located laterally in each of the thoracic hemisegments (T1-T3), readily identifi-
able by the expression of the factors Ap and Eyes absent (Eya). All four Ap neurons are part of
the last-born cells of the NB5-6T neuroblast, within which extensive regulatory cascades have
been shown to determine the specific fate of each of the neurons of this cluster. These include
the Tv1 and Tv4 neuropeptidergic neurons (expressing Nplp1 and FMRFamide, respectively),
and also the Tv2 and Tv3 neurons [8–19]. Intriguingly, the Tv4 neuron requires a target-
derived retrograde signal, mediated by BMP ligand Glass bottom boat (Gbb) activation of
BMP signaling, to terminally differentiate and activate the FMRFa gene [11, 20]. This makes
FMRFa expression in Tv4 neurons an excellent model for addressing the molecular genetic
aspects of retrograde instructive signals during nervous system development.
A recent genetic screen looking for genes involved in Tv4 specification, using an FMRFa-
eGFP transgene, identified the genes l(3)72Ab (FlyBase denomination; herein referred to as
brr2) and Prp8 [21]. brr2 encodes a small ribonucleoprotein (snRNP) type DExD/H
Box ATPase with helicase activity, while Prp8 encodes a PROCT domain protein, both of
which associate with the snRNAs U5 complex and are principal components of the spliceo-
some [22]. Apart from their well-established role in splicing, most notably in yeast, very little is
known about Brr2 and Prp8 function. The human ortholog of brr2, BRR2 has been described
to be involved in retinitis pigmentosa disease (RP) [23, 24], but no role in cell specification.
Neural specification by cell-specific splicing activity
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Here, we address the function of brr2 and Prp8, focusing on brr2 and its putative role in
RNA processing in the acquisition of Tv4 neuronal fate. Our results conclude that brr2 plays a
key and highly specific role controlling the specification of the Tv4 neuron identity. This con-
trol is fulfilled by two mechanisms that lead to the activation of the BMP retrograde signaling
pathway: (1) correct axonal pathfinding to the target tissue, essential to receive the BMP ligand
and, (2) specific RNA processing of the transcripts encoding the BMP receptor subunit Thick-
veins (Tkv) and Medea, part of the Smad complex, both essential for TGF-β receptor signaling
pathway activity. These data demonstrate that specific RNA processing plays a key role in
ensuring proper TGFβ/BMP target-derived signalling, and extends our knowledge of the post-
transcriptional mechanisms involved in diversifying neuronal identity.
Results
Loss-of-function of brr2 interferes with terminal specification but not the
generation of the Ap cluster neurons
Previously, an EMS forward genetic screen using an FMRFa-eGFP transgene, a marker for the
restricted expression of proFMRFa in the Tv4 neuron, was performed to find key genes
involved in the NB5-6T lineage specification. This screen resulted in the identification of sev-
eral mutants displaying specification defects in the NB5-6T lineage, including two nonsense
alleles for the brr2 gene (FlyBase l(3)72Ab), brr209C117 and brr213A036, and also one allele of
Prp8 [21]. Here, we focus on the role of brr2 in the NB5-6T Apterous cluster (Ap cluster) speci-
fication at Drosophila embryonic stage AFT (Air-Filled Trachea, i.e. 18h after egg laying).
Initially, we analyzed expression of the terminal markers, proFMRFa and Nplp1 neuropep-
tides, in brr2 mutants. These neuropeptides show a highly restricted expression pattern in the
VNC. ProFMRFa is expressed in the Tv4 neuron of the Ap cluster (T1-T3) and in two SE2
neurons, while Nplp1 is expressed in the Tv1 neuron of the thoracic Ap cluster (T1-T3) and in
the dorsal medial row Ap neurons (dAp neurons, T1-A10; summarized in Fig 1A). Antibody
staining of proFMRFa in brr2 mutants revealed a complete lack of expression of proFMRFa in
the Tv4 neurons of the Ap clusters (Fig 1B–1D). Expression of proFMRFa was not affected in
the SE2 cells, revealing a restricted function of brr2 to the Ap cluster. Similarly, antibody stain-
ing of Nplp1 in brr2 mutants revealed the loss of Nplp1 expression in the Tv1 Ap cluster cells,
but not in dAp cells (Fig 1C and 1D). The complete absence of both terminal markers and the
restriction of the phenotype to the Ap cluster cells in the VNC led us to postulate that Ap clus-
ter cells are not generated, perhaps due to premature cell death or early defects in the NB5-6T
lineage. To test this, we analyzed the Ap cluster cells by immunostaining for Eyes absent (Eya),
which is present in the four Ap cluster cells at St16 [12]. Eya immunostaining revealed that all
Ap cells were present in brr2 mutants at this stage (Fig 2A–2J).
We conclude that brr2 mutants generate Ap cluster neurons, but expression of the terminal
differentiation markers proFMRFa and Nplp1 is specifically affected. This phenotype is not
observed to other proFMRFa- or Nplp1-expressing neurons (SE2 or dAp cells), which sug-
gests a specific role for brr2 in the determination of neuropeptidergic identity in Ap cluster
neurons.
Temporal and sub-temporal transcriptional cascades of the Ap cluster are
not affected in brr2 mutants
The identity of each cell of the Ap cluster is achieved through an orchestrated expression of
transcription factors [8–19]. In order to study the onset of these complex genetic cascades in
brr2 mutants, we performed immunostaining at St16 for key transcription factors, Cas, Col,
Neural specification by cell-specific splicing activity
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Grh, Sqz, and Nab. At this stage, Ap cluster cells have not acquired their final identity but the
combinatorial expression of these factors allow for the identification of Tv1-Tv4 cells during
their specification and early differentiation [8, 13]. We found no apparent alteration in the
expression of Cas, Col, Grh, Sqz, or Nab in the Ap cluster cells in brr2 mutants (Fig 2A–2J).
These results revealed that the NB 5-6T lineage progresses normally and correctly generates
each of the Ap cluster cells.
brr2 is necessary for the expression of Nplp1 in Tv1 and Dimm and pMad
in Tv4 neurons.
Next, to further resolve the brr2 phenotype, we analyzed the expression of several transcription
factors that act during late stages of Ap neuron differentiation, and are necessary for Tv1 and
Tv4 neuropeptidergic identities [13]. In the Tv1 neuron, Ap and Eya activate the expression of
Dimmed (Dimm), and all three genes, together with Col, trigger Nplp1 expression [13]. In the
Tv4 neuron, Ap and Eya also activate Dimm that, together with other two factors, the phos-
phorylated form of Mothers against dpp (pMad) and Dachshund (Dac), trigger the expression
of proFMRFa [11–13]. Therefore, we analyzed the expression of these factors in the Ap cluster
cells (Fig 3A–3H).
Fig 1. Expression of the Nplp1 and proFMRFa neuropeptides is lost in brr2mutants. (A) Schematic representation of proFMRFa
and Nplp1 neuropeptide expression pattern in the VNC, in control and brr2 mutants. (B-C) Immunostaining for proFMRFa and
Nplp1 in control (B) and brr2 mutant (C, brr209c117/brr13A036) embryo CNS at AFT. (D) Quantification of proFMRFa and Nplp1
expressing cells within the Ap cluster, in control and brr2 mutants (Pearson’s chi-squared test; n>54 Ap clusters per genotype;  =
p<0.001).
https://doi.org/10.1371/journal.pgen.1007496.g001
Neural specification by cell-specific splicing activity
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We did not find differences in expression of either Ap, Eya, Col, and Dac between control
and brr2 mutant embryos (Fig 3A–3H). In contrast, the expression of Dimm was lost in one of
the two Dimm-positive cells (Tv1 and Tv4) in all Ap clusters (Fig 3D). Taking advantage of
Col immunostaining, which is restricted to Tv1 neurons within the Ap cluster at the AFT
stage, we found that Dimm was selectively lost in 100% of Tv4 neurons, in brr2 mutants
(n = 24 Ap clusters) (Fig 3I and 3J).
Fig 2. Temporal and sub-temporal regulators of Apterous neuron specification are not affected in brr2 mutants. (A-J)
Expression of Eyes absent (Eya; marking Ap neurons) and the temporal and sub-temporal factors; Castor (Cas), Collier (Col),
Squeeze (Sqz), Nab and Grainy head (Grh) in the Ap cluster (2–5 focal plane projections), in control and brr2 mutants (brr209c117/
brr13A036), at St16. Expression of all five factors appears unaltered in brr2 mutants, when compared to control.
https://doi.org/10.1371/journal.pgen.1007496.g002
Neural specification by cell-specific splicing activity
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Fig 3. Apterous cell fate determinants are affected in brr2 mutants. (A-H) Expression of the late factors in the Ap
cell fate specification cascade: Eya, Col, Dimmed (Dimm), phosphorylated form of Mothers against dpp (pMad),
Dachshund (Dac), and by the reporter line ap-Gal4>UAS-GFP, in control and brr2 mutants (brr209c117/brr13A036), at
stage AFT (2–5 focal plane projections). (I-J) Co-localization of Dimm and Col in Ap clusters (together identifying the
Tv1 neuron), in control and brr2 mutants (brr209c11/brr13A036) (2–5 focal plane projections). Expression of Dimm is
unperturbed in the Tv1 neuron in brr2 mutants. (K-L) Expression of ap, based on the ap-Gal4>UAS-GFP reporter
GFP expression, and Svp, in the Ap cluster, in control and brr2 mutant (brr209c117/brr13A036), at stage AFT. (M-O)
Summary of the expression of the late specification factors in the Ap cluster cells (Tv1-Tv4), in control and brr2
mutants.
https://doi.org/10.1371/journal.pgen.1007496.g003
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We previously reported that Svp represses Dimm expression in Tv2 and Tv3 neurons [25],
and the timed reduction of Svp expression in Tv1 and Tv4 de-represses Dimm and neuropep-
tide expression in those neurons by Stg17 [25,26]. Hence, mis-regulation of Svp may explain
the absence of Dimm in the Tv4 neuron. However, immunostaining did not reveal differences
in Svp expression (Fig 3K and 3L).
In addition to the partial loss of Dimm, pMad expression was almost completely abolished
in brr2 mutants (97% n = 49; p<0,001) (Fig 3F). Segments T1, T2 and T3 were similarly
affected. However, pMad staining could be still detected in other cells outside the Ap cluster
(S1A–S1F Fig), demonstrating that there was no general defect on the phosphorylation of
pMad. To further address if the BMP signaling defect observed in brr2 mutants was limited to
the Ap cluster we analyzed another peptidergic neuronal subtype, the Insulin-like peptide 7
(Ilp7) neurons, which also require BMP signalling for the proper Ilp7 expression [27]. Surpris-
ingly, both Ilp7 and pMad expression was completely unaffected in these neurons in brr2
mutants (S2B and S2D Fig). Additionally, we quantified the total number of pMad-positive
cells in thoracic and abdominal segments in brr2 mutants and did not find significant differ-
ences when compared to control (S1A–S1F Fig).
Our results demonstrate that brr2 is necessary for the expression of pMad, Dimm and
proFMRFa in Tv4 neurons, and for Nplp1 in Tv1 neurons.
Axonal pathfinding of Tv4 neurons is disrupted in brr2 mutants
Tv4 neurons project their axons towards the midline and exit the VNC at the dorsal midline,
to innervate a peripheral secretory gland; the dorsal neurohemal organ (DNH). When the
axon reaches the DNH, it receives the TGFβ/BMP ligand Glass bottom boat (Gbb), which
results in the phosphorylation of Mad (pMad), triggering the expression of the FMRFa neuro-
peptide gene[11–20]. Therefore, the absence of pMad in brr2 mutants could be due to defects
at different points of this process, including problems with BMP signaling, as well as axon
pathfinding problems.
Because proFMRFa is absent in brr2 mutants, the lack of markers prevented us from identi-
fying the Tv4 neuron and follow its axon trajectory. Thus, in order to address possible defects
in the axonal pathfinding of Tv4 neurons during its innervation of the DNH, we monitored
the axon pathfinding of the Ap cluster through the expression of CD8::GFP under the promo-
tor of ap gene, using the Gal4-UAS system [28] in combination with the reporter buttonless-
lacZ (btn-LacZ), which identifies the DNH. 3D analysis of this staining revealed that while Tv4
always reached the DNH in controls it failed to do so in brr2 mutants (Fig 4A and 4B and S2
Video). These results indicate that in brr2 mutants, Tv4 axons fail to receive the Gbb ligand
and therefore fail to phosphorylate Mad.
BMP receptor function in Tv4 neurons is disrupted in brr2 mutants
Previous studies described the failure of Mad phosphorylation upon a failure of axonal path-
finding to the DNH, in sqz mutants and upon misexpression of robo in Ap-neurons [11]. In
both cases, ectopic expression of gbb in Tv4 rescued Mad phosphorylation and proFMRFa
expression. In order to elucidate if BMP signaling is not triggered in brr2 mutants merely due
to defective axonal pathfinding, we ectopically expressed gbb in the Ap cluster of brr2 mutants
using the ap-Gal4 driver (ap>gbb), and performed immunostaining of pMad and proFMRFa
(Fig 4I–4P). Surprisingly, we found that expression of Gbb in the Ap neurons failed to restore
pMad or proFMRFa expression in brr2 mutants. This suggested that expression and/or pro-
cessing of other components in the BMP signaling pathway may be affected.
Neural specification by cell-specific splicing activity
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The BMP signaling pathway is triggered by binding of Gbb to a hetero-tetrameric receptor
complex, formed by Wishful thinking (Wit), Saxophone (Sax) and Thickveins (Tkv), and Tkv/
Sax-kinase activity to phosphorylate Mad, which is transported to the nucleus to act as a tran-
scription factor, in a complex with the co-Smad, Medea [29]. To address if BMP receptor
expression/assembly was affected in brr2 mutants, we ectopically expressed constitutively
active forms of Sax (UAS-saxA) and Tkv (UAS-tkvA) [30], previously shown to restore
proFMRFa expression in mutants of BMP signaling pathway receptors [11,31]. To this end, we
used two different drivers: elav-Gal4 (elav>saxA, tkvA; brr2) and ap-Gal4 (ap-Gal4> saxA, tkvA;
brr2). We observed a partial rescue of brr2 mutants in both cases (29.8% n = 84 p<0.001 and
29.8% n = 47 P>0.001, respectively) (Fig 5A–5D). This suggested that defects in receptor
expression/assembly may in part underlie the brr2 phenotype. Nevertheless, the rescue was less
Fig 4. Axonal pathfinding and BMP pathway activation are affected in brr2 mutants. (A-B) Expression of proFMRFa, ap-
Gal4>UAS-GFP and buttonless-lacZ (btn>lacZ), in control and brr2 mutant (brr209c117) VNCs, at stage AFT (thoracic segments
T1-T3). (A) In control, the six lateral Tv4 neurons project their axons (GFP- and proFMRFa-positive) into the three dorso-medial
DNHs (btn>lacZ expressing; dashed circles). Box inset shows close-up on one DNH. (B) In brr2 mutants, the three DNHs are
present, but Tv4 neurons fail to innervate the organ. (C-D) Transgenic expression of gbb in the Ap cluster of brr2 mutants (ap>gbb;
brr209c117) fails to rescue proFMRFa and pMad (2–5 focal plane projections; stage AFT).
https://doi.org/10.1371/journal.pgen.1007496.g004
Neural specification by cell-specific splicing activity
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Fig 5. Rescue of proFMRFa expression in brr2mutants by ectopic expression of active forms of BMP receptor. (A-D)
Expression of FMRFa-eGFP and proFMRFa, in control, brr2 mutants, and brr2 mutants rescued by transgenic expression of
activated BMP receptors (saxA and tkvA), at stage AFT (thoracic segments T1-T3). (A) In control, the six Tv4 neurons express both
FMRFa-eGFP and proFMRFa. The SE2 neurons (arrows) express proFMRFa but not FMRFa-eGFP, due that this reporter uses a
Tv4-specific enhancer [21, 32]. (B) In brr2 mutants (brr209c117) expression of proFMRFa and FMRFa-eGFP expression is lost in Tv4
neurons, while proFMRFa is not affected in SE2 neurons. (C-D) Transgenic expression of saxA and tkvA in brr2 mutants (brr209c117),
from ap-Gal4 (C) or elav-Gal4 (D) results in partial rescue of FMRFa-eGFP and proFMRFa (double-positive cells = white dashed
circle; GFP-positive cells only = yellow dashed circle). (E) Quantification of FMRFa-eGFP expressing cells within the Ap cluster in
control, brr2 mutants, ap>gbb;brr2, ap>saxA tkvA;brr2 and elav>saxA tkvA (Pearson’s chi-squared test, n>47 Ap clusters per
genotype;  = p<0.001; n.s = non-significant). (F-K) Expression of FMRFa-GFP and ap>RFP, identifying the Tv4 cell body and its
axon, in control and ap>saxA tkvA; brr2 mutants (brr209c117), at stage AFT (dorsal, mid and ventral views of T2 segment of the VNC).
(F-H) In control, the Tv4 axon (arrows) project to the midline, and then dorsally into the DNH (dashed circle). (I-K) In ap>saxA
tkvA;brr2, rescued mutants, Tv4 cells project their axon normally towards the midline, but fails to project dorsally into the DNH.
Instead, the axon follows the same trajectory as the rest of the Ap cluster neurons (ap>RFP), projecting ipsilaterally and anteriorly.
https://doi.org/10.1371/journal.pgen.1007496.g005
Neural specification by cell-specific splicing activity
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robust than anticipated. This could potentially explained by FMRFa mRNA processing defects,
partial rescue of Mad phosphorylation or perhaps Dimm expression.
To confirm that brr2 affected transcription of the FMRFa gene, as opposed to the processing
and translation of the FMRFa mRNA, we analyzed the expression of the FMRFa-eGFP reporter
gene; a construct with the previously identified FMRFa Tv enhancer of 446 bp inserted
upstream of eGFP [21, 32]. We found that expression of eGPF was lost hand-in-hand with the
proFMRFa immunostaining (Fig 5B).
We postulated that the lack of Dimm, observed in Tv4 neurons in brr2 mutants, may
underlie the partiality of the rescue. However, further analysis of the rescue did not reveal any
correlation between the presence of Dimm and the rescue of proFMRFa (S4D and S4E Fig).
Indeed, we observed partial rescue of Dimm expression in ap-Gal4> saxA, tkvA; brr2 (63%
n = 82 clusters p>0,001, S4F Fig). With regards pMad, we found that pMad was rescued in the
majority of Tv4 neurons, in ap-Gal4> saxA, tkvA; brr2 embryos (89% n = 47 P> 0,001, S4I
Fig). Thus, a lack of pMad rescue did not fully account for the partial proFMRFa rescue.
The rescue of proFMRFa expression in a subset of Tv4 neurons, in ap-Gal4>saxA, tkvA;
brr2 embryos, allowed us to track those axons in brr2 mutants. We found that the Tv4 axon
initially projects normally towards the midline, but subsequently fails to project dorsally into
the DNH. Instead, it follows the same trajectory as the rest of the Ap cluster neurons, project-
ing ipsilaterally and anteriorly (Fig 5F–5K, S3 and S4 Videos).
Our results reveal that brr2 has a crucial role in the specification of Tv4 identity through
both axonal pathfinding and BMP signaling, both of which are essential for proFMRFa neuro-
peptide expression.
BMP receptor activity is interrupted in Tv4 by an impairment of splicing
Brr2 is an important component of the U5 subunit of the spliceosome. To address whether the
defects observed in brr2 mutants were indeed related to a defect in splicing activity, we ana-
lyzed Prp8, which encodes another component of the U5 subunit of the spliceosome and has
been described as a regulator of Brr2 in mRNA processing [22, 33–35]. Prp8 was also identified
in the FMRFa-eGFP genetic screen as a gene showing loss of eGFP expression [21]. If the phe-
notype of brr2 in Tv4 neurons is due to its splicing activity, we expected to find a phenocopy in
Prp8 mutants. To this end, we performed immunostaining of proFMRFa, Dimm and pMad in
Prp8 mutants at AFT. Our results revealed an absence of proFMRFa specifically in Ap cluster
(S6A–S6C Table). The loss of Dimm and pMad expression in Prp8 mutants resembled that
found in brr2 mutants (S5 Fig).
The phenocopy of brr2 and Prp8 mutants suggested that Tv4 cell differentiation defects
result from their roles as components of the spliceosome. The selective effect of brr2 and Prp8
on Ap neurons stands in contrast to their described roles as essential and ubiquitous compo-
nents of the spliceosome [36, 37] (Figs 1C and 5). This prompted us to attempt to unravel
which specific genes were responsible of the defective differentiation of the Ap cluster neurons.
To this end we performed RNA-Seq analysis of RNA extracted from control, brr2 and Prp8
St15-AFT embryos. The RNA-Seq data were analyzed both for splicing aberrations and for
gene expression changes. Focusing first on splicing aberrations, our results (S1–S5 Tables)
revealed 1338 significantly altered splicing events (|ΔC|> 0.03 and q< 0.25) in brr2 and 855
Prp8, with 512 being common to both mutants (Fig 6D and 6E; S1 Table). Among the com-
mon genes identified, only the BMP receptor tkv is known to play a role in Ap cluster specifica-
tion. Specifically, we found that tkv shows defective splicing involving an alternative first exon
(AFE) in both brr2 and Prp8 mutants (|ΔC| = 0.03163; qvalue = 0.1448; pvalue = 0.0234). In
the case of brr2, the AFE path E5-E6 is favored, which is predicted to generate the shorter
Neural specification by cell-specific splicing activity
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Fig 6. BMP pathway components are affected by impaired splicing. (A-C) Expression of proFMRFa and Nplp1 in control (A),
brr2 mutants (B) and Prp8mutants (C). Both brr2 and Prp8mutants display loss of proFMRFa and Nplp1 expression in the Ap
cluster, while SE2 and dAp neurons are unaffected. (D) Venn diagram summary of genes affected in brr2 mutants, as revealed by
RNA-Seq transcription and splicing analysis. (E) Venn diagram summary of splicing events detected in both brr2 and Prp8mutants.
(F) Schematic representation of splicing events of tkv, detected in both brr2 and Prp8mutants. (G) Comparison of the deduced
amino acid sequence of the Tkv-PA protein isoform (deduced from the tkv-RA mRNA transcript) and tkv-PC (deduced from tkv-
RD). The signal peptide (red, SignalP-4.1 software prediction) is present in Tkv-PA but not in Tkv-PC, which is the isoform that is
more abundant in brr2 and Prp8mutants. Tkv-PA and Tkv-PC do not differ in other protein domains.
https://doi.org/10.1371/journal.pgen.1007496.g006
Neural specification by cell-specific splicing activity
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protein isoform tkv-PD (509 aa). The PD isoform generates a protein with unaltered Tkv
transmemebrane and kinase domains but lacking the signal peptide (Fig 6F). This protein iso-
form is less efficient in its ability to bind ligand and may be involved in dosage-dependent tkv-
ligand interactions [38]. The RNA-seq results showed that isoform tkv-PA was still present in
brr2 mutants, but since the RNA was extracted from whole embryo it remains unclear whether
or not Tv4 neurons express both isoforms.
In addition, in brr2 mutants, but not in Prp8, we also found defective splicing of Medea.
Medea encodes an ortholog of the co-smad Smad4, which complexes with phosphorylated
Receptor Smads (Smad1,5,9 in vertebrates and Mad in Drosophila), to form the Smad complex
which translocates to the nucleus to act as transcriptional regulator. In the case of brr2
mutants, the Exon Skipped (ES) E4 is favored, which generates the Med-RB isoform where the
fourth exon is absent. In vitro studies have shown that the presence or absence of the alterna-
tive fourth exon does not affect Medea binding activity [39]. Nevertheless, the behavior of
Medea isoforms in vivo is unknown. Medea amorphic alleles that affect all isoforms eliminate
proFMRFa expression in Tv4 neurons but roles for specific isoforms have not been rigorously
discriminated (personal communication Anthony Berndt and Douglas Allan).
In order to determine if pMad is properly transported into the nucleus, we analyzed the co-
localization of pMad antibody and the nuclear marker DAPI in ap-Gal4>saxA, tkvA; brr2
genetic background. We found an apparently unaltered nuclear localization of pMad (S4G and
S4H Fig). Nevertheless, we cannot rule out that the mis-spliced Medea variant affects DNA-
binding efficiency, and hence, defective splicing of Medea could be contributing to the lack of
proFMRFa found in brr2 mutants. Indeed, the limited efficiency of the genetic rescue suggests
a contribution of Medea to the brr2 phenotype.
We performed Gene Ontology (GO) enrichment analysis in order to elucidate if brr2
mutant splicing defects are more prevalent in neuronal specification due to the observed effect
upon proFMRFa. However, our results revealed that brr2 mutants were affected in many pro-
cesses and molecular functions, albeit with some prevalence for nuclear components, cyto-
plasm and plasma membrane components (S6 Fig). Regarding axonal guidance related genes
(GO 0007411), 57 genes showed significant splicing events (S7B Fig, S7 Table), which may
explain the brr2 Tv4 axon pathfinding defects.
In addition to the splicing events detected, transcriptome analysis by RNA-Seq revealed
3,780 genes with 2-fold changed expression (up- or down-regulated) in brr2 mutants (Fig 6D,
S7 Table). From the genes related to BMP signaling pathway, only screw was affected. Regard-
ing axonal guidance, 8 genes were up or downregulated in brr2 mutants (S7B Fig, S7 Table).
Summarizing, the splicing defects observed in brr2 mutants lead to an increase of the tkv-
PD spliced form, which is less efficient with respect to the binding of the ligand. This would
hamper receptor assembly, the phosphorylation of Mad and therefore the specification of Tv4
neuron. This result agrees with our previous observations, in particular the loss of pMad stain-
ing and the partial rescue of brr2 mutants by expression of saxA and tkvA but not with gbb.
Discussion
Cell-specific alternative role of an ubiquitous spliceosome component
In this study, we describe a cell-specific role of Brr2 in controlling the specification of the neu-
ropeptidergic identity of the Tv4 neuron in the embryonic Drosophila Central Nervous System
(CNS). This control is achieved through its role in three different steps necessary for the Tv4
neuron specification: (1) the axon pathfinding; (2) Dimm expression; and (3) activation of the
BMP signalling. The role of Brr2 in the spliceosome complex has been widely studied and it is
known to be essential for proper RNA processing[22, 40]. Brr2 has also been identified as a
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fundamental component of the alternative splicing process in Drosophila [17], and in addition,
brr2 expression is ubiquitous in Drosophila [36, 37]. These findings prompted us to anticipate
a widely defective splicing pattern. However, our RNA-Seq analysis revealed that a limited
number of genes were affected. Furthermore, our genetic analysis show that while brr2 is nec-
essary for proFMRFa and Nplp1 expression in the Ap cluster, expression of these neuropep-
tides in other cells in the VNC (SE2 cells for proFMRFa and dAp for Nplp1) was not affected.
In addition, after a detailed analysis of pMad expression along the VNC of brr2 mutants, we
are not able to find differences with respect to the wild type pMad expression. This set of
results demonstrates that the roles of ubiquitous components of the spliceosome can be highly
cell-type selective.
Why Brr2 activity is restricted to promoting BMP signalling only in the Tv4 neuron of the
Ap cluster, but not in other areas of the VNC, remains unclear. tkv and Medea are key compo-
nents of the BMP signalling pathway and act in a number of neurons projecting out of the
CNS. However, the number of pMad-positive neurons is not affected in brr2 mutants. Protein-
protein interaction has been described between Eya and Brr2 in a co-immunoprecipitation
analysis in Drosophila [41]. The same study also described a similar interaction between Prp8
and Ap. It is tempting to speculate that these interactions could allow specific recruitment/
activity of the spliceosome complex in Ap cluster cells, granting efficiency and specificity to
this component of the spliceosome. The association between transcription and splicing is fre-
quent and increases expression efficiency [42, 43]. Examples of these phenomena can be found
in Drosophila Mef2 transcription factor family, where integration of both processes is involved
in muscle fibre specification [2]. Moreover, cell-specific splicing events have been previously
reported in the Drosophila nervous system, for instance with regards to splicing of the Dscam
gene [44–46].
Brr2 mutants show a specific but pleiotropic phenotype
Although the role of brr2 in the Tv4 neuron has been delimitated with high resolution in the
case of the post-transcriptional effects upon tkv and Medea, the underlying mechanisms in the
axonal pathfinding defects and the lack of Dimm expression observed in Tv4 neurons remains
unresolved. Regarding the pathfinding phenotype, the RNA-Seq analysis in this study revealed
significant changes in 8 genes and splicing defects in 57 genes related to axon guidance. The
specific role, if any, of each of these genes in the Ap cluster is unknown. Nevertheless, our
study has identified clear candidate genes which, together with the well-described axonal path-
finding of Tv4, provide an excellent starting point for studying axonal guidance. Using specific
mutant backgrounds and co-expression of different splicing variants identified in this study, it
would be possible to shed light into the function of those genes, not only at the expression level
but with regards to different isoforms, as have been previously described for the axon pathfind-
ing gene lola [47, 48]. With respect to Dimm, our RNA-Seq analysis did not identify any
defects in known genes which could explain the lack of its expression, which suggest that fur-
ther analysis is required to identify more genes related to Nplp1 and proFMRFa neuropeptide
expression.
The low efficiency of the rescue mediated via expression of active forms of tkv and sax
(apterous-Gal4>saxA, tkvA) suggests that Brr2 could be regulating additional components
downstream of pMad. The nuclear localization of pMad in a subset of cells where proFMRFa
was not restored suggests that the splicing defects in Medea are not interfering with its func-
tion, at least with respect to its translocation to the nucleus. Indeed, these results match those
from in vitro studies wherein this mRNA isoform encodes a Medea protein with apparently
normal DNA-binding activity [39]. Nevertheless, its behavior in vivo is unknown and we
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cannot rule out that changes in the Medea splicing may affect the function of the Med/pMad
complex in other ways, maybe related to cofactor binding as well as DNA-binding.
The specification of Tv4 neurons requires an elaborate gene cascade, which converges to
activate the expression of the FMRFa neuropeptide gene [8, 10–14, 32]. One of the necessary
components in this cascade is retrograde BMP signalling, and a number of events are necessary
to activate the BMP signalling in the Tv4 neuron. Here, we demonstrate how the brr2 gene reg-
ulates this process at three different points: Control of pathfinding of the Tv4 axon, which is
necessary for BMP ligand reception and regulation of proper splicing of two crucial players of
the BMP signalling pathway, tkv and Medea.
In summary, here we report post-transcriptional mechanisms that sculpt neural architec-
ture at a cell-specific level, controlling precise aspects of cell development that together define
precise and discrete cell identities. This increases our understanding of how alternative splic-
ing is utilized during neural development. Future studies will be needed to determine if simi-
lar cell-specific splicing mechanisms is utilized in other lineages contributing to neural
diversity, and emerging new technologies and bioinformatics for RNA studies will facilitate
this work.
Methods & materials
Fly stocks
UAS-myr-mRFP, FMRFa-eGFP, brr209c117; UAS-myr-mRFP, FMRFa-eGFP, brr13A036; UAS-
myr-mRFP, FMRFa-eGFP, Prp804p024 [21]. From Bloomington Drosophila Stock Center:
apmd544 (referred to as apGal4, BL#3041), elav-GAL4 2 (referred to as elav-Gal4, BL#8765),
UAS-mCD8GFP (BL#8746). Other stocks used: UAS-gbb, UAS-saxa, UAS-tkva, btn-lacZ [11].
Mutants were maintained over GFP- or YFP-marked balancer chromosomes. As wild type,
OregonR or w1118 was used. Staging of embryos was performed according to Campos-Ortega
and Hartenstein [49].
Immunohistochemistry
Immunohistochemistry was performed as previously described [8]. Antibodies used were:
guinea pig anti-Col (1:1000); guinea pig anti-Dimm (1:1000); chicken anti-proNplp1 (1:1000);
rabbit anti-proFMRFa (1:1000) [13]. Mouse anti-Seven up (1:50) (Y. Hiromi, National Insti-
tute of Genetics, Mishima, Japan). Rabbit anti-pMad (1:500) (41D10, Cell Signaling Technol-
ogy). Mouse mAb Eya10H6 (1:250) (from Developmental Studies Hybridoma Bank). Rabbit
α-Cas (1:250) [50]. Rat α-Sqz (1:750) [51]. Rat α-Grh (1:1000) [8]. Rabbit α-Nab (1:1000) [52].
Rabbit α-Ilp7 (1:1000) (Miguel-Aliaga, Irene, London institute of Medical Sciences, Imperial
College London, UK). All polyclonal sera were pre-absorbed against pools of early embryos.
Secondary antibodies were conjugated with FITC, Rhodamine-RedX or Cy5 and used at 1:500
(Jackson ImmunoResearch). Embryos were dissected in PBS, fixed for 25 minutes in 4% para-
formaldehyde, blocked and processed with antibodies in PBS with 0.2% Triton X-100 and 4%
donkey serum. Slides were mounted with Vectashield (Vector Labs). Wild type and mutant
embryos were stained and analyzed on the same slide.
Confocal imaging and data acquisition
Zeiss LSM700 or Zeiss LSM800 confocal microscopes were used for fluorescent images; confo-
cal stacks were merged using LSM software or Fiji software [53]. Images and graphs were com-
piled in Adobe Illustrator.
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RNA-sequencing and differential alternative splicing analysis
Two biological replicates of frozen collections of St15-AFT embryos control (Orizo2),
brr209C117 and Prp804P024 (50 mg) were used for RNA extraction, using RNeasy Mini Kit (Qia-
gen, Hilden, Germany). Sample RNA yield was measured with a NanoDrop, precipitated in
ethanol, and then sent to GeneWiz (GeneWiz, New Jersey, NJ) for library preparation and
sequencing. Yield was checked, upon receipt of each sample, by use of NanoDrop, Qubit RNA
Assay and Agilent Bioanalyzer. The samples were fragmented after RNA QC, reverse tran-
scribed with random primers, and barcode tagged. Sequencing was performed by on the Illu-
mina Hiseq 2500, in 1x50 bp single-read sequencing configuration (the output was stored as
FASTQ-files,), which yielded 31–38 million reads/sample. The FASTQ-files were aligned
against the dmel reference genome (Release 6, RefSeq GCF_000001215.4) and raw reads were
normalized as reads per kilobase-length of gene per million mapped sequence reads (RPKM).
Differential alternative splicing (DAS) analysis was performed as described [54–57]. Raw
RNA-Seq reads were aligned to Drosophila melanogaster (dm3) genome using STAR (version
2.5.1b) [58] with default settings, and only uniquely mapped reads were retained to compute
the number of reads for exons and exon-exon junctions in each sample using the Python pack-
age HTSeq [59], with the annotation of the UCSC Ensembl gene annotation (dm3_ensGene)
[60]. Dirichlet-multinomial distribution was used to formulate the counts of the reads that
were aligned to each isoform of each event [61], and the likelihood ratio test was used to test
the significance of the changes in alternative splicing between brr2 or Prp8 mutants and con-
trols [62]. The Benjamini-Hochberg procedure was applied to calculate the adjusted q-values
from the p-values in the likelihood ratio test [63]. Seven types of differential alternative splicing
events are tested, including Exon skipping (ES), Alternative 5’ splice sites (A5SS), Alternative
3’ splice sites (A3SS), Mutually exclusive exons (ME), Intron retention (IR), Alternative first
exons (AFE) and Alternative last exons (ALE) [64]. In addition, Percent Spliced In (PSI, C)
was first computed to examine the percentage of the inclusion of variable exons in the exon-
skipping events compared to the both isoforms [65], which is extended to evaluate splicing
changes of all the seven splicing types in our DAS analysis. Particularly, the PSI was calculated
as the percentage usage of the longer isoform compared to total mRNAs for ES, A5SS, A3SS,
ME and IR. However, the PSI was calculated as the percentage of the usage of the proximal iso-
form, where the isoform with the variable exon is closer to the constitutive exon, for AFE and
ALE. The differential alternative splicing events were identified under |ΔC|> 0.03 and
q< 0.25.
Gene Ontology enrichment analysis was performed using GeneCodis3 for GO Biological
process, GO Molecular function, and Go cellular component; lowest annotation levels, Hyper-
geometric statistical test, FDR P-value correction [66–68].
Statistical analysis
Pearson’s chi-squared test, Monte Carlo, Student’s t-test, were performed using SPSS v.23
(IBM; for specific statistical test used, see text and figures). Microsoft Excel 2010 was used for
data compilation and graphical representation.
Supporting information
S1 Table. Significant splicing events common to brr2 and Prp8 mutants (|ΔC| >0,03;
q<0.25). Values relative to the splicing events associated with the respective gene region (Fly-
Base gene symbol), using the Benjamini-Hochberg procedure. ES (Exon skipping), A5SS
(Alternative 5’ splice sites), A3SS (Alternative 3’ splice sites), ME (Mutually exclusive exons),
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IR (Intron retention), AFE (Alternative first exons) and ALE (Alternative last exons), C (PSI,
percent Spliced).
(XLSX)
S2 Table. Significant splicing events in brr2 mutants (|ΔC|>0,03; q<0.25). Values relative
to the splicing events associated with the respective gene region (FlyBase gene symbol), using
the Benjamini-Hochberg procedure. ES (Exon skipping), A5SS (Alternative 5’ splice sites),
A3SS (Alternative 3’ splice sites), ME (Mutually exclusive exons), IR (Intron retention), AFE
(Alternative first exons) and ALE (Alternative last exons), C (PSI, percent Spliced).
(XLSX)
S3 Table. Significant splicing events in Prp8 mutants (|ΔC| >0,03; q<0.25). Values relative
to the splicing events associated with the respective gene region (FlyBase gene symbol), using
the Benjamini-Hochberg procedure. ES (Exon skipping), A5SS (Alternative 5’ splice sites),
A3SS (Alternative 3’ splice sites), ME (Mutually exclusive exons), IR (Intron retention), AFE
(Alternative first exons) and ALE (Alternative last exons), C (PSI, percent Spliced).
(XLSX)
S4 Table. Differential alternative splicing (DAS) analysis data of brr2 mutants. Numerical
data related to DAS analysis. Event_id: contains the gene cluster, chromosome, strand, posi-
tion, gene ID, and exon path information. Event_type: ES (Exon skipping), A5SS (Alternative
5’ splice sites), A3SS (Alternative 3’ splice sites), ME (Mutually exclusive exons), IR (Intron
retention), AFE (Alternative first exons) and ALE (Alternative last exons). Path1: the exonic
part numbers for the first path. Path2: the exonic part numbers for the second path. logoddsB/
logoddsW: log-odds of for brr2 mutants and control respectively, It represent the comparison
between the expression level of one splicing isoform to the other. Logoddratio: the log odds-
ratio between brr2 mutants and Control. pval: p-value. qval: q-value. PSI_B: Percent Spliced In
(C) for brr2. PSI_W: Percent Spliced In (C) for control. Delta_PSI: increment of C when
compared brr2 to control.
(XLSX)
S5 Table. Differential alternative splicing (DAS) analysis data of Prp8 mutants. Numerical
data related to DAS analysis. Event_id: contains the gene cluster, chromosome, strand, posi-
tion, gene ID, and exon path information. Event_type: ES (Exon skipping), A5SS (Alternative
5’ splice sites), A3SS (Alternative 3’ splice sites), ME (Mutually exclusive exons), IR (Intron
retention), AFE (Alternative first exons) and ALE (Alternative last exons). Path1: the exonic
part numbers for the first path. Path2: the exonic part numbers for the second path. logoddsP/
logoddsW: log-odds of for Prp8 mutants and control respectively, It represent the comparison
between the expression level of one splicing isoform to the other. Logoddratio: the log odds-
ratio between Prp8 mutants and Control. pval: p-value. qval: q-value. PSI_P: Percent Spliced
In (C) for Prp8. PSI_W: Percent Spliced In (C) for control. Delta_PSI: increment of C when
compared Prp8 to control.
(XLSX)
S6 Table. Gene expression levels 2-fold up- or down-regulated in brr2 mutants. Values rela-
tive to the gene (FlyBase gene symbol) expression levels with 2-fold change in brr2, expressed
as RPKM (Reads Per Kilobase per Million). The table also shows a comparison of the expres-
sion levels detected for those same genes in Prp8 mutants. brr2 and Prp8 fold change is related
to the control expression level. GO ID indicates gene ontology identification term/terms asso-
ciated with the relative gene.
(XLSX)
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S7 Table. Expression levels and splicing events detected for genes with the “TGF-β receptor
signaling pathway” GO identifier in brr2 mutants. Values relative to the gene (FlyBase gene
symbol) expression levels expressed as fold change, and splicing events for genes with the
“TGF-β receptor signaling pathway” GO identifier in brr2 mutants. Expression in CNS is indi-
cated (FlyBase, BDGP). ES (Exon skipping), A5SS (Alternative 5’ splice sites), A3SS (Alterna-
tive 3’ splice sites), ME (Mutually exclusive exons), IR (Intron retention), AFE (Alternative
first exons) and ALE (Alternative last exons).
(XLSX)
S8 Table. Expression levels and splicing events detected for genes with the “axon guidance”
GO identifier affected in brr2 mutants. Values relative to the gene (FlyBase gene symbol)
expression levels expressed as fold change, and splicing events for genes with the “axon guid-
ance” GO identifier affected in brr2 mutants. ES (Exon skipping), A5SS (Alternative 5’ splice
sites), A3SS (Alternative 3’ splice sites), ME (Mutually exclusive exons), IR (Intron retention),
AFE (Alternative first exons) and ALE (Alternative last exons).
(XLSX)
S9 Table. Spreadsheet form of numerical data and summary statistics. Numerical data
related to graphs and summary statistics in the Figs 1, 3, 5, S1, S4 and S5.
(XLSX)
S1 Fig. Related to Fig 3. Expression of PMad in thoracic and abdominal segments of VNC
in brr2 mutants. (A-F) Expression of pMad in control (A, D) and brr2 mutant (B,E) thoracic
segments of stage AFT embryos. Eya (in thorax) and Dimm (in abdomen) immunostaining
was used to identify neuropeptide expressing cells and provide a reference for delimiting the
segments (dashed lines). Quantification of pMad within the segments did not show any signifi-
cant difference in brr2 mutants, when compared to control (Student’s t-test, thorax n>9
embryos per genotype; abdomen n = 3 embryos per genotype).
(EPS)
S2 Fig. Ilp7 expression is not affected in brr2 mutants. (A-D) Expression of Ilp7, Dimm,
pMad and FMRFa-GFP reporter, in control and brr2 (brr209c117). Ilp7 expression not affected
in Ilp7 neurons (dashed lines) in brr2 mutants. Identification, using Dimm, of the previously
described four Ilp7 expressing neurons (C-D dashed lines), which are BMP signaling depen-
dent, revealed pMad expression in brr2 mutants, indicating that the BMP pathway is active.
(EPS)
S3 Fig. Related to Fig 4. Ectopic expression of the BMP ligand Gbb in brr2 mutants. (A-B)
Ap cluster neurons (white arrows), identified by ap-Gal4>UAS-GFP, immunostained for
FMRFa and Nplp1, in control and in brr2 mutants ectopically expressing gbb (ap>gbb;brr2).
Transgenic expression of gbb does not result in rescue of FMRFa expression.
(EPS)
S4 Fig. Related to Fig 5. Characterization of FMRFa rescue. (A-C) Expression of
FMRFa>GFP (FMRFa), ap>RFP and pMad, in ap-Gal4;brr2 mutants (brr209c117) transgeni-
cally expressing saxA and tkvA, at AFT. pMad expression is rescued in the Ap cluster by ectopic
expression of active forms of Tkv and Sax, although FMRFa expression is not restored in every
segment (B). (A) and (C) show magnification of squares “1” and “2” depicted in (B). More
than one cell in the Ap cluster shows expression of pMad (variable expression level). (D-E)
Expression of FMRFa>GFP (FMRFa), ap>RFP reporter and Dimm in ap-Gal4;brr2 mutants
(brr209c117) transgenically expressing saxA and tkvA, at AFT. FMRFa rescue does not correlate
with Dimm expression (arrows). (F) Quantification of Dimm expressing cells in control, brr2
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mutants and ap-Gal4;brr2 mutants (brr209c117) expressing saxA and tkvA (ap-Gal4 sax[A] and
tkv[A]; brr2; Pearson’s chi-squared test, n>34 Ap clusters per genotype,  = p<0.05;  =
p<0.001). (G-H) Expression of FMRFa>GFP (FMRFa), ap>RFP and pMad, combined with
DAPI staining, in ap-Gal4;brr2 mutant (brr209c117) expressing saxA and tkvA, T2 segments,
right and left of the same embryo. pMad nuclear localization appears to be independent of
FMRFa rescue. (I) pMad expressing cluster quantification (referred as Ap cluster with at
least one strong pMad expressing cell) in control, brr2 mutants and ap-Gal4;brr2 mutants
(brr209c117) expressing saxA and tkvA (ap-Gal4 saxA and tkvA;brr2; Pearson’s chi-squared test,
n>34 Ap clusters per genotye;  = p<0.001).
(EPS)
S5 Fig. Related to Fig 6. Prp8 phenocopies brr2 mutants. (A-F) Confocal, 2–5 layer projec-
tion images of the Ap cluster showing expression pattern of the late factors in the specification
cascade by immunostaining of Eyes absent (Eya), Dimmed (Dimm) and phosphorylated form
of Mothers against dpp (pMad) in Prp8 mutants (Prp804p024; E-F) compared to the pattern pre-
viously observed in control (A-B) and brr2 mutant (brr209c117/ brr13A036; C-D) embryos, at
stage AFT. (G) Quantitative analysis of the SE2 FMRFa cells size in control, brr2 mutant
(brr209c117/ brr13A036), ap-Gal4;brr2 mutants (brr209c117) expressing saxA and tkvA (ap> saxA
and tkvA;brr2) and elav-Gal4;brr2 mutants (brr209c117) expressing saxA and tkvA (elav> saxA
and tkvA;brr2).
(EPS)
S6 Fig. Related to Fig 6. Top Gene Ontology terms affected in brr2 mutants. (A) Gene
Ontology (GO) enrichment analysis of genes showing splicing events in brr2 mutants (Gene-
Codis). (B) Gene Ontology (GO) enrichment analysis of genes showing 2-fold transcription
changes in brr2 mutants (GeneCodis).
(EPS)
S7 Fig. Related to Fig 6. Top Gene Ontology terms affected in brr2 mutants (b). (A) Gene
Ontology (GO) enrichment analysis of genes showing both splicing events and 2-fold tran-
scription changes in brr2 mutants (GeneCodis). (B) Venn diagram showing axon guidance
affected genes in brr2 mutants.
(EPS)
S1 Video. Related to Fig 4. Dorsal neurohemal organ inervation by apterous cluster neu-
rons in control. 3D reconstruction video from confocal images showing the axonal pathfind-
ing of Ap cluster neurons (ap>GFP, green) innervating the dorsal neurohemal organ (DHN,
buttonless-lacZ, blue) in the thoracic segments T2-T3 of control flies at stage AFT.
(MP4)
S2 Video. Related to Fig 4. Dorsal neurohemal organ innervation failure by apterous clus-
ter neurons in brr2 mutants. 3D reconstruction video from confocal images showing the axo-
nal pathfinding of Ap cluster neurons (ap>GFP, green) and the absence of innervation to the
dorsal neurohemal organ (DHN, buttonless-lacZ, blue) in the thoracic segments T2-T3 of brr2
mutant flies at stage AFT.
(MP4)
S3 Video. Related to Fig 5. Tv4 neuron axonal pathfinding in control. 3D reconstruction
video from confocal images showing the axonal pathfinding of the Ap cluster (ap> RFP, red)
and the Tv4 neurons (FMRFa>GFP, green) in the thoracic segment T3 of control flies at stage
AFT. The reconstruction shows Tv4 projection to the midline and then dorsal, establishing a
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ramified pattern (DHN inervation).
(MP4)
S4 Video. Related to Fig 5. Tv4 neuron axonal pathfinding in brr2 mutants with rescued
FMRFa expression. 3D reconstruction video from confocal images showing the axonal path-
finding of the Ap cluster (ap> RFP, red) in brr2 mutants rescued by transgenic expression of
activated BMP receptors (saxA and tkvA). Expression of FMRFa-eGFP reporter make possible
to identify the Tv4 neuron. The segment shown (T2) present partial rescue of FMRFa expres-
sion on one cluster (FMRFa>GFP, green, at the starting frame, cell located on the right side)
but not in the other (left side). The reconstruction shows Tv4 cell projecting their axon nor-
mally towards the midline, but fails to project dorsally into the DNH. Instead, the axon follows
the same trajectory as the rest of the Ap cluster neurons (ap>RFP), projecting ipsilaterally and
anteriorly.
(MP4)
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